Mimedx Group Stock Market Value
| MDXG Stock | USD 9.16 0.28 2.97% |
| Symbol | MiMedx |
MiMedx Group Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.1) | Earnings Share 0.59 | Revenue Per Share 2.447 | Quarterly Revenue Growth 0.029 | Return On Assets 0.1838 |
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MiMedx 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MiMedx's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MiMedx.
| 11/17/2024 |
| 12/17/2024 |
If you would invest 0.00 in MiMedx on November 17, 2024 and sell it all today you would earn a total of 0.00 from holding MiMedx Group or generate 0.0% return on investment in MiMedx over 30 days. MiMedx is related to or competes with Monte Rosa, Design Therapeutics, Werewolf Therapeutics, Ikena Oncology, Stoke Therapeutics, Century Therapeutics, and Edgewise Therapeutics. MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare More
MiMedx Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MiMedx's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MiMedx Group upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.84 | |||
| Information Ratio | 0.1433 | |||
| Maximum Drawdown | 26.54 | |||
| Value At Risk | (2.97) | |||
| Potential Upside | 3.19 |
MiMedx Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MiMedx's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MiMedx's standard deviation. In reality, there are many statistical measures that can use MiMedx historical prices to predict the future MiMedx's volatility.| Risk Adjusted Performance | 0.1265 | |||
| Jensen Alpha | 0.6516 | |||
| Total Risk Alpha | 0.2376 | |||
| Sortino Ratio | 0.3247 | |||
| Treynor Ratio | 2.48 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MiMedx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MiMedx Group Backtested Returns
MiMedx appears to be somewhat reliable, given 3 months investment horizon. MiMedx Group has Sharpe Ratio of 0.17, which conveys that the firm had a 0.17% return per unit of volatility over the last 3 months. By analyzing MiMedx's technical indicators, you can evaluate if the expected return of 0.71% is justified by implied risk. Please exercise MiMedx's risk adjusted performance of 0.1265, and Mean Deviation of 2.1 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, MiMedx holds a performance score of 13. The company secures a Beta (Market Risk) of 0.27, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MiMedx's returns are expected to increase less than the market. However, during the bear market, the loss of holding MiMedx is expected to be smaller as well. Please check MiMedx's expected short fall, and the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether MiMedx's current price movements will revert.
Auto-correlation | -0.46 |
Modest reverse predictability
MiMedx Group has modest reverse predictability. Overlapping area represents the amount of predictability between MiMedx time series from 17th of November 2024 to 2nd of December 2024 and 2nd of December 2024 to 17th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MiMedx Group price movement. The serial correlation of -0.46 indicates that about 46.0% of current MiMedx price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.46 | |
| Spearman Rank Test | -0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
MiMedx Group lagged returns against current returns
Autocorrelation, which is MiMedx stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MiMedx's stock expected returns. We can calculate the autocorrelation of MiMedx returns to help us make a trade decision. For example, suppose you find that MiMedx has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
MiMedx regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MiMedx stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MiMedx stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MiMedx stock over time.
Current vs Lagged Prices |
| Timeline |
MiMedx Lagged Returns
When evaluating MiMedx's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MiMedx stock have on its future price. MiMedx autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MiMedx autocorrelation shows the relationship between MiMedx stock current value and its past values and can show if there is a momentum factor associated with investing in MiMedx Group.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:Check out MiMedx Correlation, MiMedx Volatility and MiMedx Alpha and Beta module to complement your research on MiMedx. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
MiMedx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.